Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism MRPL22 modulators(mitochondrial ribosomal protein L22 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gram-Negative Bacterial Infections | Preclinical | CN | 01 Mar 2024 | |
Gram-Positive Bacterial Infections | Preclinical | CN | 01 Mar 2024 |